UP0 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Ultragenyx Pharmaceutical Inc

Watchlist Manager

Watchlist

Price: 21.24 EUR 1.19%

Market Cap: €2.7B

U	Ultragenyx Pharmaceutical Inc SWB:UP0	US
	Banca Monte dei Paschi di Siena SpA MIL:BMPS	IT
J	Jumia Technologies AG SWB:4JMA	DE
K	Kingsgate Consolidated Ltd XMUN:KCN	AU
I	ICF International Inc F:G6V	US
S	Smart Digital Group Ltd NASDAQ:SDM	SG
P	Poly Medicure Ltd BSE:531768	IN
	Alliance Global Group Inc OTC:ALGGY	PH
C	Cable One Inc F:XC1	US

Profitability Summary

Ultragenyx Pharmaceutical Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

84%

Strong 3Y Average Gross Margin

87%

Declining Gross Margin

91% > 84%

Negative Operating Margin

-84%

Negative 3Y Average Operating Margin

-109%

Operating Margin is Increasing

-174% > -84%

Negative Net Margin

-91%

Negative 3Y Average Net Margin

-116%

Net Margin is Increasing

-187% > -91%

Negative Free Cash Flow Margin

-76%

Negative 3Y Average Free Cash Flow Margin

-95%

Free Cash Flow Margin is Increasing

-138% > -76%

Exceptional ROE

1 327%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-71%

ROIC is Increasing

-92% > -70%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.